1. Home
  2. DOMH vs BRTX Comparison

DOMH vs BRTX Comparison

Compare DOMH & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dominari Holdings Inc.

DOMH

Dominari Holdings Inc.

HOLD

Current Price

$2.34

Market Cap

53.1M

Sector

Health Care

ML Signal

HOLD

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

HOLD

Current Price

$2.55

Market Cap

3.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOMH
BRTX
Founded
1967
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Managed Health Care
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.1M
3.7M
IPO Year
2010
2015

Fundamental Metrics

Financial Performance
Metric
DOMH
BRTX
Price
$2.34
$2.55
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 237.7K
193.3K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
★ 23.45%
N/A
EPS Growth
★ 34.03
N/A
EPS
N/A
★ N/A
Revenue
★ $123,104,000.00
$81,000.00
Revenue This Year
N/A
$298.39
Revenue Next Year
N/A
$64.62
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 578.41
N/A
52 Week Low
$1.91
$0.14
52 Week High
$7.54
$4.10

Technical Indicators

Market Signals
Indicator
DOMH
BRTX
Relative Strength Index (RSI) 49.03 59.17
Support Level $2.29 $0.22
Resistance Level $3.39 $4.10
Average True Range (ATR) 0.19 0.21
MACD 0.04 -0.03
Stochastic Oscillator 57.69 0.00

Price Performance

Historical Comparison
DOMH
BRTX

About DOMH Dominari Holdings Inc.

Dominari Holdings Inc is a holding company that, through its various subsidiaries, is engaged in wealth management, investment banking, sales and trading, asset management, and insurance. In addition to capital investment, Dominari provides management support to the executive teams of its subsidiaries, helping them to operate efficiently and reduce costs under a streamlined infrastructure. The Company operates in two reportable business segments: Dominari Financial and Legacy AIkido, with the majority of revenue from Dominari Financial.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.

Share on Social Networks: